National Peroxide Reports Decline in Q2 FY26 Revenue and Profit

NPL , a key player in the hydrogen peroxide manufacturing sector, has reported its financial results for the second quarter and first half of the fiscal year 2025-26, revealing a decline in both revenue and profit compared to the previous year.

Q2 FY26 Performance

For the quarter ended September 30, 2025, NPL recorded:

Metric	Q2 FY26	Q2 FY25	YoY Change
Revenue from Operations	₹6,828.63 crore	₹7,702.33 crore	-11.3%
Profit After Tax	₹38.59 crore	₹67.91 crore	-43.2%
Basic EPS	₹0.67	₹1.18	-43.2%

The company's revenue from operations decreased by 11.3% year-over-year, while profit after tax saw a significant decline of 43.2%.

H1 FY26 Overview

For the half-year ended September 30, 2025:

Metric	H1 FY26	H1 FY25	YoY Change
Revenue from Operations	₹13,494.15 crore	₹15,101.18 crore	-10.6%
Profit After Tax	₹127.62 crore	₹576.28 crore	-77.9%

The company's half-yearly performance also showed a downturn, with revenue decreasing by 10.6% and profit after tax declining sharply by 77.9% compared to the same period last year.

Financial Position

As of September 30, 2025, NPL reported:

Total Assets: ₹43,969.33 crore
Equity Share Capital: ₹574.70 crore
Other Equity: ₹34,351.80 crore

Operational Highlights

NPL continues to operate in a single segment, focusing on the manufacturing of hydrogen peroxide. The company's board of directors approved these unaudited financial results at their meeting held on November 3, 2025.

Market Implications

The decline in revenue and profit may raise concerns among investors about the company's performance in the current economic environment. Factors such as raw material costs, market demand for hydrogen peroxide, and overall industry trends could be influencing these results.

Investors and analysts may want to closely monitor the company's future guidance and any strategic initiatives to address the declining performance in the coming quarters.

NPL continues to be a significant player in the chemical industry, particularly in the hydrogen peroxide segment. The company's ability to navigate current market challenges and return to growth will be crucial for its future performance and market position.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.33%	-5.19%	-2.18%	-5.61%	-42.10%	-13.48%

NPL has announced the resignation of Mr. Pravin Shetty from his positions as Chief Financial Officer (CFO) and Chief Risk Officer (CRO). The company made this disclosure in compliance with regulatory obligations.

Resignation Details

Mr. Shetty tendered his resignation on September 15, 2025, citing personal reasons. According to the company's filing, his last working day is scheduled for September 19, 2025. This information was conveyed to the stock exchange as part of National Peroxide's regulatory requirements under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Company's Statement

In the official communication, National Peroxide Limited stated:

"Mr. Pravin Shetty, Chief Financial Officer (CFO), Chief Risk Officer (CRO) of the Company, has tendered his resignation from the post of CFO & CRO, due to personal exigencies. His last working day with the organisation will be September 19, 2025."

Regulatory Compliance

The company has provided the necessary disclosures as required by SEBI regulations, including details of the change in key managerial personnel. This transparency ensures that shareholders and potential investors are kept informed about significant changes within the organization's leadership.

About National Peroxide Limited

National Peroxide Limited, formerly known as NPL Chemicals Limited, is a company registered under CIN: L24290MH2020PLC342890. The company's registered office is located at Neville House, J. N. Heredia Marg, Ballard Estate, Mumbai - 400 001.

As the company begins the process of identifying a successor for the CFO and CRO positions, stakeholders will be keenly watching for further announcements regarding the appointment of new key managerial personnel.